Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

I believe (and gosh darn demand) that the company get a RIGS partner and/or a 4694 partner immediately. This will turn things around perpetually. This would be the best case for NAVB, assuming of course, that we also get both expected FDA approvals later this year and European approval (which seems to be dragging on for no good reason that the shareholder is aware of). Lymphoseek alone does not make Navidea a 2.00 stock with abominable sales quarter after quarter. I do not think we will be on the April or May European calendar given the ridiculous delay that continues with Eurpope. June will be wonderful for EU approval, but who knows...

The worst case for NAVB from here on out imo, is the complete abandonment of RIGS, the complete failure of 4694, and the complete failure of 5001. Along the way, as these pipeline products fail or are abandoned, another share offering (or two) will occur and the stock will go under 1.00, never again to trade above 1.00.